Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, tolerability, and efficacy of NDI-219216 in patients with advanced solid tumors, including MSI-H cancers; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Microsatellite Instability-high Cancer

Drugs mentioned

• NDI-219216

Snippet

Sponsor: Nimbus Wadjet, Inc. | Conditions: Advanced Solid Tumors Cancer, MSI-H Cancer | Phase 1, Phase 2 | Status: RECRUITING